We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Recent 510(k) Guidances May Mean Continued Jumps in NSE Rate
Recent 510(k) Guidances May Mean Continued Jumps in NSE Rate
The number of 510(k) submissions found not substantially equivalent could rise following recent FDA guidance blocking the use of split predicates and establishing expectations for benefit-risk determinations, say legal experts.